Literature DB >> 32027358

Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.

Gregory Olson1, Andrew M Davis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32027358     DOI： 10.1001/jama.2019.21118

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  Challenges in the virtual assessment of COVID-19 infections in the community.

Authors:  Warren J McIsaac; Ross Upshur; Sahana Kukan
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

2.  Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.

Authors:  Ya-Lin Jiang; Hong-Yan Liu; Min-Min Tang; Jia-Yi Cheng; Hui Zhao; Lin Fu
Journal:  Front Med (Lausanne)       Date:  2022-06-17

3.  The Association Between Prescribed Opioid Receipt and Community-Acquired Pneumonia in Adults: a Systematic Review and Meta-analysis.

Authors:  Catherine Steffens; Minhee Sung; Lori A Bastian; E Jennifer Edelman; Alexandria Brackett; Craig G Gunderson
Journal:  J Gen Intern Med       Date:  2020-09-03       Impact factor: 5.128

4.  Impact of comorbid asthma on severity of coronavirus disease (COVID-19).

Authors:  Sang Chul Lee; Kang Ju Son; Chang Hoon Han; Ji Ye Jung; Seon Cheol Park
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

5.  Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia.

Authors:  Mutlu Kuluöztürk; Erdal İn; Selda Telo; Ercan Karabulut; Ayşegül Altıntop Geçkil
Journal:  J Med Virol       Date:  2021-02-17       Impact factor: 20.693

6.  Predictive and Prognostic Utility of the Serum Level of Resistin-Like Molecule Beta for Risk Stratification in Patients with Community-Acquired Pneumonia.

Authors:  Li Chen; Qiongzhen Luo; Ying Shang; Xinwei He; Yu Xu; Zhancheng Gao
Journal:  Pathogens       Date:  2021-01-25

7.  Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.

Authors:  Zheng Xu; Xin-Ming Wang; Peng Cao; Chen Zhang; Chun-Mei Feng; Ling Zheng; De-Xiang Xu; Lin Fu; Hui Zhao
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

Review 8.  Ischemic stroke associated with COVID-19: a systematic review and meta-analysis.

Authors:  Wenzhang Luo; Xiang Liu; Kunyang Bao; Changren Huang
Journal:  J Neurol       Date:  2021-10-15       Impact factor: 6.682

9.  Identifying Prokineticin2 as a Novel Immunomodulatory Factor in Diagnosis and Treatment of Sepsis.

Authors:  Xiaoyan Yu; Jingyi Chen; Hong Tang; Qianqian Tu; Yue Li; Xi Yuan; Xuemei Zhang; Ju Cao; David Paul Molloy; Yibing Yin; Dapeng Chen; Zhixin Song; Pingyong Xu
Journal:  Crit Care Med       Date:  2022-04-01       Impact factor: 9.296

10.  Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial.

Authors:  Jose Lenin Beltran Gonzalez; Mario González Gámez; Emanuel Antonio Mendoza Enciso; Ramiro Josue Esparza Maldonado; Daniel Hernández Palacios; Samuel Dueñas Campos; Itzel Ovalle Robles; Mariana Jocelyn Macías Guzmán; Andrea Lucia García Díaz; César Mauricio Gutiérrez Peña; Lucila Martinez Medina; Victor Antonio Monroy Colin; Jose Manuel Arreola Guerra
Journal:  Infect Dis Rep       Date:  2022-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.